v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Restricted Stock
RSUs
Common Stock
Common Stock
RSUs
Additional Paid-In Capital
Additional Paid-In Capital
Restricted Stock
Additional Paid-In Capital
RSUs
Accumulated Deficit
Accumulated Deficit
Restricted Stock
Accumulated Deficit
RSUs
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024       24,017,599                
Beginning balance at Dec. 31, 2024 $ 81,255     $ 23   $ 197,489     $ (115,721)     $ (536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Long term incentive program charges 1,179         1,179            
Post-combination compensation charge-shares 605         605            
Vesting of stock issued from acquisitions 0         1     (1)      
Repayment of note receivable by related party (in shares)       (63,356)                
Repayment of note receivable by related party (532)         (532)            
Share-Based Accounting Charge 7,444         7,444            
Foreign currency translation gain (loss) 721                     721
Net loss (10,614)               (10,614)      
Ending balance (in shares) at Mar. 31, 2025       23,954,243                
Ending balance at Mar. 31, 2025 80,058     $ 23   206,186     (126,336)     185
Beginning balance (in shares) at Dec. 31, 2024       24,017,599                
Beginning balance at Dec. 31, 2024 81,255     $ 23   197,489     (115,721)     (536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock for settlement of other liability 342                      
Foreign currency translation gain (loss) 2,242                      
Net loss (16,346)                      
Ending balance (in shares) at Jun. 30, 2025       24,906,408                
Ending balance at Jun. 30, 2025 81,050     $ 23   217,155     (137,833)     1,705
Beginning balance (in shares) at Mar. 31, 2025       23,954,243                
Beginning balance at Mar. 31, 2025 80,058     $ 23   206,186     (126,336)     185
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Long term incentive program charges 1,148         1,148            
Issuance of unvested legally outstanding shares (in shares)       719,547                
Forfeiture, Retained Pre-UK IPO shares (in shares)       (2,630)                
Dividends (5,765)               (5,765)      
Post-combination compensation charge-shares 893         893            
Issuance common stock for acquisition (in shares)       134,915                
Issuance of common stock for acquisition 1,190         1,190            
Issuance of common stock for settlement of other liability 342         342            
Vesting of restricted stock units (in shares)         100,333              
Vesting of restricted stock awards and units   $ 0 $ 0       $ 1 $ 1   $ (1) $ (1)  
Share-Based Accounting Charge 7,394         7,394            
Foreign currency translation gain (loss) 1,520                     1,520
Net loss (5,730)               (5,730)      
Ending balance (in shares) at Jun. 30, 2025       24,906,408                
Ending balance at Jun. 30, 2025 $ 81,050     $ 23   217,155     (137,833)     1,705
Beginning balance (in shares) at Dec. 31, 2025 25,174,492     25,174,492                
Beginning balance at Dec. 31, 2025 $ 74,904     $ 24   237,075     (163,381)     1,186
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Long term incentive program charges 1,530         1,530            
Issuance of unvested legally outstanding shares (in shares)       16,579                
2026 U.S. IPO Issuance, net of underwriting discounts and offering expenses (in shares)       3,742,500                
2026 U.S. IPO Issuance, net of underwriting discounts and offering expenses 35,949     $ 4   35,945            
Forfeiture, Retained Pre-UK IPO shares (in shares)       (4,794)                
Post-combination compensation charge-shares 1,042         1,042            
Share-Based Accounting Charge 7,282         7,282            
Foreign currency translation gain (loss) (323)                     (323)
Net loss (11,497)               (11,497)      
Ending balance (in shares) at Mar. 31, 2026       28,928,777                
Ending balance at Mar. 31, 2026 $ 108,887     $ 28   282,874     (174,878)     863
Beginning balance (in shares) at Dec. 31, 2025 25,174,492     25,174,492                
Beginning balance at Dec. 31, 2025 $ 74,904     $ 24   237,075     (163,381)     1,186
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock for settlement of other liability 1,211                      
Foreign currency translation gain (loss) (353)                      
Net loss $ (15,230)                      
Ending balance (in shares) at Jun. 30, 2026 29,895,289     29,895,289                
Ending balance at Jun. 30, 2026 $ 110,943     $ 28   295,734     (185,653)     834
Beginning balance (in shares) at Mar. 31, 2026       28,928,777                
Beginning balance at Mar. 31, 2026 108,887     $ 28   282,874     (174,878)     863
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Long term incentive program charges 2,018         2,018            
Offering cost reclassification (148)         (148)            
Issuance of unvested legally outstanding shares (in shares)       713,380                
Forfeiture, Retained Pre-UK IPO shares (in shares)       (885)                
Dividends (7,041)               (7,041)      
Post-combination compensation charge-shares 690         690            
Issuance of common stock for settlement of other liability 1,211         1,211            
Issuance of common stock for settlement of contingent consideration 1,727         1,727            
Vesting of restricted stock units (in shares)         254,017              
Share-Based Accounting Charge 7,362         7,362            
Foreign currency translation gain (loss) (29)                     (29)
Net loss $ (3,734)               (3,734)      
Ending balance (in shares) at Jun. 30, 2026 29,895,289     29,895,289                
Ending balance at Jun. 30, 2026 $ 110,943     $ 28   $ 295,734     $ (185,653)     $ 834